Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 8/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.51 |
| ▸ | GNPAT | O15228 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30547342 | 1.00 | BACE1 (0.53) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL31672257 | 0.97 | MMP2 (0.53) | BACE1GNPATMMP2 | |
| SCHEMBL30688850 | 0.96 | GNPAT (0.53) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL29630562 | 0.95 | MMP2 (0.55) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL31482981 | 0.94 | MMP2 (0.57) | BACE1NAALAD2GNPATMMP2 | |
| SCHEMBL30099515 | 0.94 | MMP2 (0.57) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL30507602 | 0.94 | GNPAT (0.56) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL31170896 | 0.94 | GNPAT (0.56) | BACE1NAALAD2FOLH1GNPATMMP2 | |
| SCHEMBL30799817 | 0.93 | MMP2 (0.55) | NAALAD2GNPATMMP2 | |
| SCHEMBL31094953 | 0.93 | NAALAD2 (0.60) | BACE1NAALAD2FOLH1GNPATCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673154-A1 | CELL THERAPY FOR TREATING SYSTEMIC AUTOIMMUNE DISEASES | Juno Therapeutics, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| US-12444491-B2 | Machine learning methods for classifying cells | JUNO THERAPEUTICS, INC. (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250297282-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20250237628-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-07-24 | — | — | US | disclosed |
| WO-2024182516-A1 | CELL THERAPY FOR TREATING SYSTEMIC AUTOIMMUNE DISEASES | JUNO THERAPEUTICS, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240285762-A1 | CELL THERAPY FOR TREATING SYSTEMIC AUTOIMMUNE DISEASES | JUNO THERAPEUTICS, INC. (US) | 2024-08-29 | — | — | US | disclosed |
| US-20240191188-A1 | METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME | JUNO THERAPEUTICS GMBH (DE) | 2024-06-13 | — | — | US | disclosed |
| EP-4334341-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | Juno Therapeutics GmbH (DE) | 2024-03-13 | — | — | EP | disclosed |
| US-11913024-B2 | Methods for culturing cells and kits and apparatus for same | JUNO THERAPEUTICS GMBH (DE) | 2024-02-27 | — | — | US | disclosed |
| US-20220392613-A1 | MACHINE LEARNING METHODS FOR CLASSIFYING CELLS | JUNO THERAPEUTICS, INC. (US) | 2022-12-08 | — | — | US | disclosed |
| WO-2022234009-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2022-11-10 | — | — | WO | disclosed |
| EP-4051402-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | Juno Therapeutics GmbH (DE) | 2022-09-07 | — | — | EP | disclosed |
| EP-4004545-A1 | METHODS OF ISOLATING A BIOLOGICAL ENTITY | Cell.copedia GmbH (DE) | 2022-06-01 | — | — | EP | disclosed |